CN1024753C - 避孕植入剂的制造方法 - Google Patents
避孕植入剂的制造方法 Download PDFInfo
- Publication number
- CN1024753C CN1024753C CN88104894A CN88104894A CN1024753C CN 1024753 C CN1024753 C CN 1024753C CN 88104894 A CN88104894 A CN 88104894A CN 88104894 A CN88104894 A CN 88104894A CN 1024753 C CN1024753 C CN 1024753C
- Authority
- CN
- China
- Prior art keywords
- implant
- eva
- vinyl acetate
- weight
- desogestrel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
Abstract
Description
Claims (4)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8701868 | 1987-08-08 | ||
NL8701868 | 1987-08-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1031323A CN1031323A (zh) | 1989-03-01 |
CN1024753C true CN1024753C (zh) | 1994-06-01 |
Family
ID=19850428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN88104894A Expired - Lifetime CN1024753C (zh) | 1987-08-08 | 1988-08-06 | 避孕植入剂的制造方法 |
Country Status (19)
Country | Link |
---|---|
US (3) | US4957119A (zh) |
EP (1) | EP0303306B1 (zh) |
JP (1) | JP2571831B2 (zh) |
KR (1) | KR950008763B1 (zh) |
CN (1) | CN1024753C (zh) |
AT (1) | ATE86484T1 (zh) |
AU (1) | AU603475B2 (zh) |
CA (1) | CA1309949C (zh) |
DE (2) | DE3879031T2 (zh) |
DK (1) | DK173166B1 (zh) |
ES (1) | ES2054784T3 (zh) |
FI (1) | FI93421C (zh) |
HK (1) | HK1002020A1 (zh) |
IE (1) | IE61730B1 (zh) |
MX (1) | MX9203817A (zh) |
NL (1) | NL980027I2 (zh) |
NZ (1) | NZ225399A (zh) |
PT (1) | PT88220B (zh) |
ZA (1) | ZA885034B (zh) |
Families Citing this family (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5114719A (en) * | 1987-04-29 | 1992-05-19 | Sabel Bernhard A | Extended drug delivery of small, water-soluble molecules |
US5156164A (en) * | 1988-10-13 | 1992-10-20 | Leveen Harry H | Iodine contraceptive sponge |
BE1002600A3 (fr) * | 1988-11-23 | 1991-04-09 | Wildemeersch Dirk | Dispositif intra-uterin perfectionne. |
IE71202B1 (en) * | 1990-12-17 | 1997-02-12 | Akzo Nv | Progestagen-only contraceptive |
WO1993017662A1 (en) * | 1992-03-02 | 1993-09-16 | Daratech Pty. Ltd. | Improved implants |
DE69329407T2 (de) * | 1992-06-02 | 2001-05-03 | Bard Inc C R | Verfahren und Implantatvorrichtung für Langzeitwirkstoffabgabe |
US5368588A (en) * | 1993-02-26 | 1994-11-29 | Bettinger; David S. | Parenteral fluid medication reservoir pump |
US5443461A (en) * | 1993-08-31 | 1995-08-22 | Alza Corporation | Segmented device for simultaneous delivery of multiple beneficial agents |
US5681817A (en) | 1994-02-04 | 1997-10-28 | The Medical College Of Hampton Roads | Treatment of ovarian estrogen dependent conditions |
US5660848A (en) * | 1994-11-02 | 1997-08-26 | The Population Council, Center For Biomedical Research | Subdermally implantable device |
US5521166A (en) * | 1994-12-19 | 1996-05-28 | Ortho Pharmaceitical Corporation | Antiprogestin cyclophasic hormonal regimen |
DE19539361A1 (de) * | 1995-10-23 | 1997-04-24 | Basf Ag | Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung |
US5733565A (en) * | 1996-02-23 | 1998-03-31 | The Population Council, Center For Biomedical Research | Male contraceptive implant |
CN1088993C (zh) * | 1996-10-11 | 2002-08-14 | 上海市计划生育科学研究所 | 含孕二烯酮的长效皮下避孕埋植剂 |
US6203813B1 (en) | 1997-01-13 | 2001-03-20 | Lance L. Gooberman | Pharmaceutical delivery device and method of preparation therefor |
TW358031B (en) * | 1997-04-11 | 1999-05-11 | Akze Nobel N V | Drug delivery system for 2 or more active substances |
DE19744135C1 (de) * | 1997-09-29 | 1999-03-25 | Schering Ag | Beschichtete medizinische Implantate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe |
ATE313422T1 (de) | 1998-05-01 | 2006-01-15 | Duramed Pharmaceuticals Inc | Verfahren zur spritzgussherstellung von vorrichtungen mit kontrollierter wirkstofffreisetzung und damit hergestellte vorrichtung |
US6117441A (en) * | 1998-07-02 | 2000-09-12 | The Population Council, Inc. | Silicone core long term androgen delivery implant |
AU4957999A (en) * | 1998-07-17 | 2000-02-07 | Pharmacia & Upjohn Company | Subcutaneous medroxyprogesterone acetate for contraception |
US6117442A (en) * | 1998-11-12 | 2000-09-12 | Leiras Oy | Drug delivery device, especially for the delivery of androgens |
US6063395A (en) * | 1998-11-12 | 2000-05-16 | Leiras Oy | Drug delivery device especially for the delivery of progestins and estrogens |
US6217895B1 (en) | 1999-03-22 | 2001-04-17 | Control Delivery Systems | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
CA2267743C (en) * | 1999-03-30 | 2011-07-26 | Robert F. Casper | Low dose estrogen interrupted hormone replacement therapy |
US6375972B1 (en) * | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
AU9177501A (en) * | 2000-08-23 | 2002-03-04 | Akzo Nobel Nv | Novel testosterone ester formulation for human use |
EP1545705A4 (en) | 2000-11-16 | 2010-04-28 | Microspherix Llc | FLEXIBLE AND / OR ELASTIC BRACHYTHERAPY SEED OR STRAND |
EP1387670B1 (en) | 2001-05-11 | 2008-10-15 | Ortho-McNeil-Janssen Pharmaceuticals, Inc. | Immune modulation device for use in animals |
HUP0400390A2 (hu) | 2001-07-02 | 2004-09-28 | Akzo Nobel N.V. | Tetrahidrokinolin-származékok és ezeket tartalmazó gyógyszerkészítmények |
WO2003017971A1 (en) * | 2001-08-31 | 2003-03-06 | Schering Oy | Drug delivery system |
ES2252540T3 (es) | 2001-09-04 | 2006-05-16 | Akzo Nobel N.V. | Tieno (2,3-d) pirimidinas glicino-sustituidas con actividad agonistas combinada lh y fsh. |
TWI228508B (en) | 2001-09-04 | 2005-03-01 | Akzo Nobel Nv | Thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity |
BR0307218A (pt) * | 2002-01-24 | 2004-12-07 | Smart Drug Systems Inc | Composição farmacêutica com liberação prolongada |
JP2005519964A (ja) * | 2002-03-11 | 2005-07-07 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | スルファターゼ阻害プロゲストゲンのみの避妊レジメン |
TWI297685B (en) | 2002-04-04 | 2008-06-11 | Organon Nv | Non-steroidal progesterone receptor modulators |
US8871241B2 (en) * | 2002-05-07 | 2014-10-28 | Psivida Us, Inc. | Injectable sustained release delivery devices |
BR0309844A (pt) * | 2002-05-07 | 2005-02-15 | Control Delivery Sys Inc | Processos para formação de um dispositivo para a distribuição de droga |
PT2561860T (pt) * | 2002-05-31 | 2018-05-08 | Titan Pharmaceuticals Inc | Dispositivo polimérico implantável para a libertação prolongada de buprenorfina |
DE60309895T2 (de) * | 2002-08-28 | 2007-10-18 | Casper, Robert-Frederic, Toronto | Estrogenersatztherapie |
US7795280B2 (en) | 2002-11-07 | 2010-09-14 | N.V. Organon | Indoles useful in the treatment of androgen-receptor related diseases |
TWI306855B (en) | 2002-12-20 | 2009-03-01 | Organon Nv | Tetrahydroquinoline derivatives |
TWI322012B (en) | 2002-12-20 | 2010-03-21 | Organon Nv | Tetrahydroquinoline derivatives |
ZA200507877B (en) | 2003-03-31 | 2007-01-31 | Titan Pharmaceuticals Inc | Implantable polymeric device for sustained release of dopamine agonist |
CA2523859C (en) | 2003-04-29 | 2011-08-02 | The General Hospital Corporation | Methods and devices for the sustained release of multiple drugs |
TWI336627B (en) * | 2003-05-23 | 2011-02-01 | Organon Nv | Drug delivery system,and use and manufacturing method thereof |
ZA200509063B (en) * | 2003-05-30 | 2007-03-28 | Titan Pharmaceuticals Inc | Impiantable polymeric device for sustained release of nalmefene |
JP2007524616A (ja) * | 2003-06-20 | 2007-08-30 | ヴァイラル・ジェノミックス・インコーポレーテッド | Hivを処置するための組成物および方法 |
WO2005070445A2 (en) * | 2004-01-13 | 2005-08-04 | Vasogenix Pharmaceuticals, Inc. | Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same |
WO2005070444A2 (en) * | 2004-01-13 | 2005-08-04 | Vasogenix Pharmaceuticals, Inc. | Methods for treating acute myocardial infarction by calcitonin gene related peptide and compositions containing the same |
CA2552677A1 (en) * | 2004-01-13 | 2005-07-28 | Vasogenix Pharmaceuticals, Inc. | Controlled release cgrp delivery composition for cardiovascular and renal indications |
TWI434676B (zh) * | 2004-03-19 | 2014-04-21 | Merck Sharp & Dohme | 可用x射線看出之藥物遞送裝置 |
TW200531977A (en) | 2004-03-25 | 2005-10-01 | Akzo Nobel Nv | Progesterone receptor modulators |
TW200602317A (en) | 2004-04-23 | 2006-01-16 | Akzo Nobel Nv | Novel androgens |
EP1629844B2 (en) | 2004-07-13 | 2012-04-18 | Bayer Schering Pharma Oy | A longterm delivery system with controlled initial burst |
PT1781264E (pt) | 2004-08-04 | 2013-10-16 | Evonik Corp | Métodos para o fabrico de dispositivis de administração e dispositivos para a mesma |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
JP2008543863A (ja) * | 2005-06-15 | 2008-12-04 | ハイドラ バイオサイエンシズ インコーポレイテッド | 精子の運動亢進のモジュレーター及びその利用 |
EP1743638A1 (en) | 2005-07-15 | 2007-01-17 | Laboratorios Del Dr. Esteve, S.A. | Pharmaceutical formulations of substituted pyrazoline compounds |
PL2359808T3 (pl) | 2006-08-09 | 2013-10-31 | Intarcia Therapeutics Inc | Osmotyczne systemy dostawcze i zespoły tłokowe |
US7989442B2 (en) | 2006-09-27 | 2011-08-02 | N.V. Organon | Progesterone receptor modulators |
CN101209238B (zh) * | 2006-12-27 | 2012-05-09 | 辽宁省计划生育科学研究院 | 含孕二烯酮的生物降解型长效皮下避孕埋植剂及其制备 |
MX2009011123A (es) | 2007-04-23 | 2009-11-02 | Intarcia Therapeutics Inc | Formulaciones de suspensiones de peptidos insulinotropicos y sus usos. |
US8063037B2 (en) | 2007-05-07 | 2011-11-22 | N. V. Organon | Progesterone receptor modulators |
CN101130057B (zh) * | 2007-07-06 | 2011-04-27 | 复旦大学 | 胸腺五肽长效植入剂及其制备方法 |
AR066166A1 (es) | 2007-09-21 | 2009-07-29 | Organon Nv | Sistema de suministro de droga |
US20100303841A1 (en) * | 2007-11-27 | 2010-12-02 | Nira Hochman | Adjuvant |
JP5502751B2 (ja) | 2007-12-20 | 2014-05-28 | エボニック コーポレイション | 低残留溶媒濃度を有する微粒子を調製するためのプロセス |
EP2240155B1 (en) | 2008-02-13 | 2012-06-06 | Intarcia Therapeutics, Inc | Devices, formulations, and methods for delivery of multiple beneficial agents |
NZ598686A (en) | 2009-09-28 | 2014-05-30 | Intarcia Therapeutics Inc | Rapid establishment and/or termination of substantial steady-state drug delivery |
CN102740830A (zh) * | 2009-12-23 | 2012-10-17 | 普西维达公司 | 缓释递送装置 |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
US10028858B2 (en) | 2011-07-11 | 2018-07-24 | Medicines360 | Intrauterine systems, IUD insertion devices, and related methods and kits therefor |
AR089765A1 (es) * | 2012-01-23 | 2014-09-17 | Bayer Oy | Un sistema para el suministro de un farmaco |
US10188426B2 (en) | 2013-02-06 | 2019-01-29 | Mark SILLENDER | Embryo transfer catheter and method |
EP2953678B1 (en) | 2013-02-06 | 2020-03-25 | Sillender, Mark | Therapeutic substance transfer catheter |
US10413504B2 (en) | 2013-12-11 | 2019-09-17 | Merck Sharp & Dohme Corp. | Intravaginal ring drug delivery system |
WO2015086489A1 (en) | 2013-12-11 | 2015-06-18 | Merck Sharp & Dohme B.V. | Drug delivery system for delivery of anti-virals |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
WO2016149561A1 (en) * | 2015-03-17 | 2016-09-22 | Oak Crest Institute Of Science | Subdermal implants for the sustained delivery of water-soluble drugs |
AU2016270984B2 (en) | 2015-06-03 | 2021-02-25 | Intarcia Therapeutics, Inc. | Implant placement and removal systems |
CN109310743A (zh) | 2016-05-16 | 2019-02-05 | 因塔西亚制药公司 | 胰高血糖素受体选择性多肽及其使用方法 |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
WO2018064544A1 (en) | 2016-09-29 | 2018-04-05 | Gesea Biosciences Inc. | Bioerodible contraceptive implant and methods of use thereof |
EP3565580B1 (en) | 2017-01-03 | 2024-03-06 | i2o Therapeutics, Inc. | Continuous administration of exenatide and co-adminstration of acetaminophen, ethinylestradiol or levonorgestrel |
US11571328B2 (en) | 2018-04-09 | 2023-02-07 | Medicines360 | IUD insertion devices |
EP3801462A4 (en) | 2018-05-24 | 2022-03-16 | Celanese EVA Performance Polymers LLC | IMPLANTABLE DEVICE FOR EXTENDED RELEASE OF A MACROMOLECULAR DRUG COMPOUND |
SG11202005949UA (en) * | 2018-05-24 | 2020-07-29 | Celanese Eva Performance Polymers Corp | Implantable device for sustained release of a macromolecular drug compound |
US20200261258A1 (en) | 2019-02-19 | 2020-08-20 | Medicines360 | Devices, systems, methods and kits for insertion and removal of iuds |
BR102020007749A2 (pt) | 2020-04-17 | 2021-11-03 | Edson Luiz Peracchi | Implante subcutâneo reabsorvível de longa duração com liberação controlada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da endometriose |
EP4159207A4 (en) | 2020-05-29 | 2024-04-17 | Peracchi Edson Luiz | LONG-LASTING SUBCUTANEOUS IMPLANT WITH SUSTAINED RELEASE OF PRE-CONCENTRATED PHARMACOLOGICAL ACTIVE SUBSTANCE IN POLYMER FOR THE TREATMENT OF CHRONIC ADRENALINE INSUFFICIENCY OR HYPOCORTISOLISM |
BR102020013862A2 (pt) | 2020-07-07 | 2022-01-18 | Edson Luiz Peracchi | Implante subcutâneo reabsorvível de longa duração com liberação sustentada de substância farmacologicamente ativa pré-concentrada em polímero para tratamento da doença de parkinson |
EP4316464A1 (en) | 2021-03-29 | 2024-02-07 | Edson Luiz Peracchi | Long-lasting resorbable subcutaneous implant with prolonged release of pre-concentrated pharmacologically active substance in polymer for the treatment of hypothyroidism, and method |
CN113209050A (zh) * | 2021-05-14 | 2021-08-06 | 浙江恒冀制药有限责任公司 | 基于生物相容性聚合物的长效体内皮埋或内植缓释制剂 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3903880A (en) * | 1972-08-17 | 1975-09-09 | Alza Corp | Intrauterine device for managing the reproductive process |
US3926188A (en) * | 1974-11-14 | 1975-12-16 | Alza Corp | Laminated drug dispenser |
US4582052A (en) * | 1982-03-23 | 1986-04-15 | Repromed, Inc. | Povidone-iodine dispensing fiber |
NZ200564A (en) * | 1982-05-10 | 1987-03-06 | Ahi Operations Ltd | Device for slowly releasing chemicals into body cavities of animals |
US4601714A (en) * | 1983-07-07 | 1986-07-22 | Burnhill Michael S | Vaginal device |
US4629621A (en) * | 1984-07-23 | 1986-12-16 | Zetachron, Inc. | Erodible matrix for sustained release bioactive composition |
US4596576A (en) * | 1984-10-12 | 1986-06-24 | Akzo N.V. | Release system for two or more active substances |
US4720384A (en) * | 1985-05-03 | 1988-01-19 | E. I. Du Pont De Nemours And Company | Manufacture of hollow fine tubular drug delivery systems |
US4673565A (en) * | 1985-05-03 | 1987-06-16 | E. I. Du Pont De Nemours And Company | Pharmaceutical compositions containing hollow fine tubular drug delivery systems |
-
1988
- 1988-07-07 DE DE8888201432T patent/DE3879031T2/de not_active Expired - Lifetime
- 1988-07-07 AT AT88201432T patent/ATE86484T1/de not_active IP Right Cessation
- 1988-07-07 ES ES88201432T patent/ES2054784T3/es not_active Expired - Lifetime
- 1988-07-07 DE DE1999175054 patent/DE19975054I2/de active Active
- 1988-07-07 EP EP88201432A patent/EP0303306B1/en not_active Expired - Lifetime
- 1988-07-11 IE IE211888A patent/IE61730B1/en not_active IP Right Cessation
- 1988-07-12 ZA ZA885034A patent/ZA885034B/xx unknown
- 1988-07-13 NZ NZ225399A patent/NZ225399A/xx unknown
- 1988-07-25 CA CA000572897A patent/CA1309949C/en not_active Expired - Lifetime
- 1988-08-01 FI FI883594A patent/FI93421C/fi not_active IP Right Cessation
- 1988-08-04 AU AU20449/88A patent/AU603475B2/en not_active Expired
- 1988-08-05 US US07/229,066 patent/US4957119A/en not_active Expired - Lifetime
- 1988-08-05 DK DK198804386A patent/DK173166B1/da active Protection Beyond IP Right Term
- 1988-08-06 CN CN88104894A patent/CN1024753C/zh not_active Expired - Lifetime
- 1988-08-06 KR KR88010063A patent/KR950008763B1/ko not_active IP Right Cessation
- 1988-08-08 JP JP63197812A patent/JP2571831B2/ja not_active Expired - Lifetime
- 1988-08-08 PT PT88220A patent/PT88220B/pt not_active IP Right Cessation
-
1990
- 1990-06-21 US US07/541,559 patent/US5088505A/en not_active Expired - Lifetime
-
1992
- 1992-02-14 US US07/836,632 patent/US5150718A/en not_active Expired - Lifetime
- 1992-06-29 MX MX9203817A patent/MX9203817A/es unknown
-
1998
- 1998-02-11 HK HK98101032A patent/HK1002020A1/xx not_active IP Right Cessation
- 1998-09-30 NL NL980027C patent/NL980027I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
HK1002020A1 (en) | 1998-07-24 |
MX9203817A (es) | 1992-08-01 |
DE3879031T2 (de) | 1993-06-24 |
DE3879031D1 (de) | 1993-04-15 |
IE882118L (en) | 1989-02-08 |
IE61730B1 (en) | 1994-11-30 |
JP2571831B2 (ja) | 1997-01-16 |
FI93421C (fi) | 1995-04-10 |
EP0303306B1 (en) | 1993-03-10 |
FI883594A0 (fi) | 1988-08-01 |
ZA885034B (en) | 1989-03-29 |
FI883594A (fi) | 1989-02-09 |
ES2054784T3 (es) | 1994-08-16 |
PT88220A (pt) | 1989-06-30 |
PT88220B (pt) | 1995-03-01 |
NL980027I1 (nl) | 1998-12-01 |
DK438688A (da) | 1989-02-09 |
NL980027I2 (nl) | 1999-02-01 |
JPS6470410A (en) | 1989-03-15 |
AU2044988A (en) | 1989-03-02 |
CN1031323A (zh) | 1989-03-01 |
KR890003360A (ko) | 1989-04-14 |
US5088505A (en) | 1992-02-18 |
US5150718A (en) | 1992-09-29 |
DK438688D0 (da) | 1988-08-05 |
EP0303306A1 (en) | 1989-02-15 |
NZ225399A (en) | 1990-09-26 |
US4957119A (en) | 1990-09-18 |
AU603475B2 (en) | 1990-11-15 |
FI93421B (fi) | 1994-12-30 |
DE19975054I2 (de) | 2000-04-13 |
CA1309949C (en) | 1992-11-10 |
KR950008763B1 (en) | 1995-08-08 |
ATE86484T1 (de) | 1993-03-15 |
DK173166B1 (da) | 2000-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1024753C (zh) | 避孕植入剂的制造方法 | |
CN1049787A (zh) | 胃逗留装置 | |
CN1170604C (zh) | 含有可相容的抗菌剂的电转运装置 | |
CN1549703A (zh) | 药物输送体系 | |
CN1062290A (zh) | 低雌激素的口服避孕药 | |
CN1794974A (zh) | 药物递送体系 | |
CN1268879A (zh) | 基于胶原蛋白的生物相容性的能吸收紫外线的光学透明的聚合材料及其制造方法 | |
CN1089867A (zh) | 低熔和/或挥发性活性物膏药 | |
CN101036633A (zh) | 一种奥美拉唑肠溶微丸胶囊及其制备方法 | |
CN1933820A (zh) | 基于聚乙烯乙酸乙烯酯共聚物的药物递送系统 | |
CN1127529A (zh) | 人白细胞介素-10的激动剂和拮抗剂 | |
CN1809643A (zh) | 在膜蛋白中插入弗林蛋白酶切割位点及其用途 | |
CN1094284A (zh) | 基于去甲基甲地孕酮衍生物的新颖组合物及其生产方法 | |
CN1896107A (zh) | 类天蚕素a-马盖宁杂合基因工程抗菌肽 | |
CN1840177A (zh) | 胸腺肽α1注射液及其制备方法 | |
CN1035986C (zh) | 持久释放的丸药组合物的制备方法 | |
CN1589133A (zh) | 不透射线的缓释药物系统 | |
CN1265798C (zh) | 含有藻酸盐的药物组合物 | |
CN101036784A (zh) | 一种乙型肝炎治疗性细胞毒性t细胞表位疫苗及其制备方法 | |
CN1638747A (zh) | 持续释放药物组合物 | |
CN1184960C (zh) | 多颗粒药剂、构成它的颗粒、制备它的方法和装置 | |
CN1899287A (zh) | 一种治疗焦虑症的缓释药物组合物及其制备方法 | |
CN101073562A (zh) | 一种牛磺酸眼用即型凝胶 | |
CN1208057C (zh) | 复方莪术油制剂及其制备方法 | |
CN1957864A (zh) | 一种TiNi形状记忆合金宫内节育器的制作方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C15 | Extension of patent right duration from 15 to 20 years for appl. with date before 31.12.1992 and still valid on 11.12.2001 (patent law change 1993) | ||
OR01 | Other related matters | ||
ASS | Succession or assignment of patent right |
Owner name: ORGANON NV Free format text: FORMER OWNER: AKZO NOVEL N.V. CORP. Effective date: 20070309 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C56 | Change in the name or address of the patentee |
Owner name: AKZO NOVEL N.V. CORP. Free format text: FORMER NAME OR ADDRESS: AKZO N. V. |
|
CP03 | Change of name, title or address |
Address after: Holland Arnhem Patentee after: AKZO NOBEL N.V. Address before: Holland Arnhem Patentee before: Akzo N |
|
TR01 | Transfer of patent right |
Effective date of registration: 20070309 Address after: Holland Patentee after: N.V. ORGANON Address before: Holland Arnhem Patentee before: AKZO NOBEL N.V. |
|
C17 | Cessation of patent right | ||
CX01 | Expiry of patent term |